JPRN-UMIN000004720招募中未知
eutralizing antibodies and clinical isolates of human immunodeficiency viruses (HIV). - Neutralizing antibodies and clinical isolates ofHIV.
Matsushita project, Center for AIDS Research, Kumamoto University0 个研究点目标入组 60 人开始时间: 2010年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who have difficulty to donate additional blood because of some complications such as severe anemia 2.Patients under treatment of immune suppressive agents or anti-cancer agents. 3.Patients under treatment with interferon. 4.Patients who are determined not appropriate for the study by attending doctors.
研究者
相似试验
进行中（未招募）
不适用
Antibodies against EBLV after immunization with Rabipurhealthy volunteersMedDRA version: 14.1Level: LLTClassification code 10069589Term: Rabies immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-002096-34-NLCrucell Holland B.V.
已完成
不适用
Research towards presence of Antibodies against European Bat Lyssavirus (EBLV) after immunization with Rabipur®10047438rabiesNL-OMON37212eids Universitair Medisch Centrum30
尚未招募
3 期
Clinical study of immunogenicity and safety of human papilloma virus vaccine (quadrivalent, produced by Biosun pharmed Co.) compared to Gardasil vaccine (quadrivalent, produced by Merck Co.) in healthy adults aged 15-35 yearsIRCT20230508058114N1Biosun pharmed pharmaceutical company450
招募中
4 期
Safety and Immunogenicity of heterologous or homologous booster after complete vaccination against COVID-19.Covid19D012141RBR-5y9y7p7Secretaria Municipal de Saúde do Rio de Janeiro
撤回
2 期
A phase I/II *minor histocompatibility antigen UTA2-1 loaded, PD-L silenced Dendritic cell vaccination trial after allogeneic Stem Cell Transplantation to improve the safety and efficacy of Donor Lymphocyte Infusions.hematological B cell malignancies blood cell cancer10027656NL-OMON43853Vrije Universiteit Medisch Centrum12